Cystamine
CAS No. 51-85-4
Cystamine( —— )
Catalog No. M33330 CAS No. 51-85-4
Cystamine (2,2'-Disulfanediyldiethanamine) is an inhibitor of transglutaminase and inhibits caspase-3 with an IC50 value of 23.6 μM. Cystamine can be used in studies about Huntington's diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 30 | In Stock |
|
| 25MG | 46 | In Stock |
|
| 50MG | 66 | In Stock |
|
| 100MG | 88 | In Stock |
|
| 500MG | 250 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCystamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionCystamine (2,2'-Disulfanediyldiethanamine) is an inhibitor of transglutaminase and inhibits caspase-3 with an IC50 value of 23.6 μM. Cystamine can be used in studies about Huntington's diseases.
-
DescriptionCystamine is the disulfide form of the free thiol, cysteamine. Cystamine is an orally active transglutaminase (Tgase) inhibitor. Cystamine also has inhibition activity for caspase-3 with an IC50 value of 23.6 μM. Cystamine can be used for the research of severals diseases including Huntington's disease (HD) .
-
In VitroCystamine has inhibition activity for caspase-3 with an IC50 value of 23.6 μM.Cystamine (0-500 μM; 0-16 h) inhibits recombinant active caspase-3 in a concentration-dependent manner. Cystamine (250 μM; 10 h) robustly increases the levels of glutathione.Western Blot Analysis Cell Line:uman neuroblastoma SH-SY5Y cells Concentration:250, 500 μM Incubation Time:0-16 h Result:Inhibited the MG132-mediated activation of caspase-3. Inhibited the H2O2-mediated activation of caspase-3. Inhibited caspase-3 activity in a tTG-independent manner.
-
In VivoCystamine (oral, i.p.; 112, 225 mg/kg) reduces Tgase activity and GGEL levels, lessens the behavioral and neuropathological severity, and extends survival in R6/2 transgenic HD mice.Animal Model:R6/2 transgenic HD mice Dosage:112, 225 mg/kg Administration:Intraperitoneal or oral, dailyResult:Significantly extended survival, improved body weight and motor performance, delayed the neuropathological sequela and significantly altered the levels of Tgase activity and N(Sigma)-(gamma-L-glutamyl)-L-lysine (GGEL) levels.
-
Synonyms——
-
PathwayApoptosis
-
TargetCaspase
-
RecptorCaspase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number51-85-4
-
Formula Weight152.28
-
Molecular FormulaC4H12N2S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (656.69 mM; Ultrasonic ) H2O : 100 mg/mL (656.69 mM; Ultrasonic)
-
SMILESNCCSSCCN
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mathieu Lesort, et al. Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders. J Biol Chem. 2003 Feb 7;278(6):3825-30. ?
molnova catalog
related products
-
Z-LEHD-fmk
Z-LEHD-FMK is a selective and potent caspase-9 inhibitor that protects against reperfusion injury and slows apoptosis. Z-LEHD-FMK exhibits antitumor and neuroprotective activity.
-
PAC1
PAC-1 is a potent procaspase-3 activator with EC50 of 0.22 μM and the first small molecule known to directly activate procaspase-3 to caspase-3.
-
Abrine
Abrine exhibits inhibition of rabbit small intestine indoleamine 2, 3-dioxygenase, competitive inhibition of IDO.
Cart
sales@molnova.com